openPR Logo
Press release

Insulin Delivery Devices Market to Witness Huge Growth in 2025 | Key Player Analysis: Tandem Diabetes Care, Inc., Eli Lilly and Company, Biocon, Owen Mumford, Ltd., Sanofi, Braun Melsungen AG, Insulet Corporation, Medtronic

10-30-2018 09:25 AM CET | Health & Medicine

Press release from: The Insight Partners

Insulin Delivery Devices Market

Insulin Delivery Devices Market

The global insulin delivery devices market is expected to reach US$ 22,830.0 Mn by 2025 from US$ 11,869.0 Mn in 2017. The market is estimated to grow with a CAGR of 8.7% during the forecast period from 2018 to 2025.

The report evaluates insulin delivery devices market dynamics effecting the insulin delivery devices market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.

Get Sample PDF Copy of Insulin Delivery Devices Market Report http://bit.ly/2CMMQ4x

Insulin is an important treatment plan for the people suffering with diabetes that helps in getting glucose from bloodstream into the muscles and fat cells to be used for fuel. Insulin is injected or infused into the fatty tissue under the skin through the delivery devices. There are numerous devices that can be used to deliver insulin, including insulin pens, insulin pumps, pen needles, insulin syringes, and jet injectors among others. The report would be of an interest to various stakeholders operating in the insulin delivery devices. These stakeholders include healthcare institutes, pharmaceutical and biotechnology therapeutics manufactures and suppliers, academic and research institutes, insulin delivery devices manufacturers and vendors, distributors and others.

Profiles of Key Insulin Delivery Devices Companies
1. BD
2. Novo Nordisk A/S
3. B. Braun Melsungen AG
4. Insulet Corporation
5. Medtronic
6. Tandem Diabetes Care, Inc.
7. Eli Lilly and Company
8. Biocon
9. Owen Mumford, Ltd.
10. Sanofi

The global insulin delivery devices market is segmented into product, end user and geography. Based on product, the insulin delivery devices market is segmented into insulin pens, insulin pumps, insulin syringes, pen needles and others. The insulin pens segment is further bifurcated into reusable and disposable segments. The insulin pumps segment is also further segmented into tube pumps and patch pumps segments. On the basis of end user, the market is segmented into patients or home care and hospitals & clinics.

The objective of the study is to describe, define, and forecast the insulin delivery devices market by product end user, and region. The report also provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall insulin delivery devices market.

If You want to Purchase the Report Directly: http://bit.ly/2CLTPL7

About The Insight Partners:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, and Telecommunication industries.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Delivery Devices Market to Witness Huge Growth in 2025 | Key Player Analysis: Tandem Diabetes Care, Inc., Eli Lilly and Company, Biocon, Owen Mumford, Ltd., Sanofi, Braun Melsungen AG, Insulet Corporation, Medtronic here

News-ID: 1338086 • Views: 134

More Releases from The Insight Partners

Automated Parcel Delivery Terminals Market Analysis and Forecasts By Leading Pla …
automated parcel delivery terminals market accounted for US$ 799.0 Mn in 2017 and is expected to grow at a CAGR of 12.0% during the forecast period 2018 – 2025, to account for US$ 1,973.4 Mn in 2025. Automated Parcel Delivery Terminals market operates in a lately introduced highly-competitive marketplace. As leading companies in this market continues to broaden its addressable market, by expanding its current product portfolio, diversifying its client base,
Detailed Research Report on Automotive Multi-Domain Controller Market to 2027
This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market in near future. Segmentation
Industrial Metrology Market 2019 PROMINENT KEY PLAYERS: Carl Zeiss Corporation, …
Measurement principles applied to manufacture processes to ensure quality as well as the accuracy of the manufactured parts and components. A system of master parts, gauges and single-use machines worked when an entire product was produced in a single factory. Modern global supply chains need a different system. Metrology can be used for many different functions, depending on multiple variables including the purpose of the study or project. Commonly, the
Freight Transport Management Market 2019 Trends, Business Growth, Leading Player …
Efficient freight transportation is essential for the economic growth of any nation. Hence, effectively managing freight transportation becomes crucial for development. Various strategies are incorporated for improving efficiency and freight and commercial transport. These include route planning, freight optimization, order management, and fuel management. The industry, in recent years, has witnessed the advent of machine-to-machine communication and analytics to enhance these operations. Furthermore, the demand shift towards digitization offers significant

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact
Global Insulin Delivery Machine Market: By Types - Insulin Pens, Insulin Pumps, …
Latest industry research report on: Global Insulin Delivery Machine Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1181480 This report studies Insulin Delivery Machine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in